<DOC>
	<DOC>NCT00852969</DOC>
	<brief_summary>The purpose of this study is to obtain information on whether raising levels of HDL-cholesterol (the "good" cholesterol) can improve how blood vessels work in kidney disease. This may help us understand the causes leading to high rates of heart disease in kidney disease and also ways to reduce this risk.</brief_summary>
	<brief_title>Niacin and Endothelial Function in Early CKD</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Diagnosis of CKD Stage 2 (GFR &gt;60 and microalbuminuria/proteinuria) and Stage 34 (GFR 1530) HDLcholesterol &lt;50 for men and &lt;55 for women If taking a statin, stable dose for past one month Glucose &lt;200 mg/dL and HbA1c &lt;9% Transplant recipients who are in stage 23 CKD; 1year post transplant; and have had no rejection episodes in the 6months prior to study entry Hospitalization within prior 3 months Any of the following conditions: uncontrolled peptic ulcer disease active liver disease OR abnormal SGOT/SGPT history of adverse reaction to niacin contraindication to aspirin concurrent fibrate therapy history of gout serum phosphorus levels below 2.7mg/dl Nursing Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>Niacin</keyword>
	<keyword>HDL</keyword>
	<keyword>Endothelial Function</keyword>
</DOC>